Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.52 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.52 |
| ▸ | KDM1A | O60341 | 3/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | F10 | P00742 | 1/20 | 0.48 |
| ▸ | F12 | P00748 | 1/20 | 0.48 |
| ▸ | F7 | P08709 | 1/20 | 0.48 |
| ▸ | F3 | P13726 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzamidoxime SCHEMBL102483 | 1.00 | KMT2A (0.58) | KMT2AMEN1GAAPOLBCYP2C19 | |
| SCHEMBL22872296 | 1.00 | KMT2A (0.58) | KMT2AMEN1GAAPOLBCYP2C19 | |
| Benzamidoxime SCHEMBL872652 | 1.00 | KMT2A (0.58) | KMT2AMEN1GAAPOLBCYP2C19 | |
| Benzamidoxime SCHEMBL9211538 | 0.97 | KMT2A (0.56) | KMT2AMEN1GAAPOLBCYP2C19 | |
| Benzamidoxime SCHEMBL27457742 | 0.97 | POLB (0.58) | KMT2AMEN1GAAPOLBCYP2C19 | |
| Benzamidoxime SCHEMBL23405829 | 0.91 | CYP2C19 (0.52) | KMT2AMEN1GAAPOLBCYP2C19 | |
| Benzamidoxime SCHEMBL28695169 | 0.91 | CYP2C19 (0.57) | KMT2AMEN1GAAPOLBCYP2C19 | |
| Benzamidoxime SCHEMBL10502994 | 0.91 | MEN1 (0.50) | KMT2AMEN1GAAPOLBCYP2C19 | |
| SCHEMBL21215226 | 0.89 | GFER (0.55) | KMT2AMEN1GAAPOLBCYP2C19 | |
| Benzamidoxime SCHEMBL27799692 | 0.89 | F2 (0.70) | KMT2AMEN1GAAPOLBCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 605 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12172972-B1 | 3-(3-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | King Faisal University (SA) | 2024-12-24 | — | — | US | claimed |
| US-12162845-B1 | 3-(4-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | King Faisal University (SA) | 2024-12-10 | — | — | US | claimed |
| US-11958816-B1 | N′-({[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl}oxy)benzenecarboximidamide as an antimicrobial compound | King Faisal University (SA) | 2024-04-16 | — | — | US | claimed |
| US-11958814-B1 | 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | King Faisal University (SA) | 2024-04-16 | — | — | US | claimed |
| US-11919871-B1 | 3-(3-chlorophenyl)-5-((2-isopropyl-5- methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | King Faisal University (SA) | 2024-03-05 | — | — | US | claimed |
| CN-113662938-B | Application of amine derivative in preparation of anti-tumor pharmaceutical composition | 广西科技大学 | 2022-08-16 | — | — | CN | claimed |
| CN-113662938-A | Application of amine derivative in preparation of anti-tumor pharmaceutical composition | 广西科技大学 | 2021-11-19 | — | — | CN | claimed |
| CN-110156769-B | Compound with xanthine oxidase inhibitory activity and preparation method and application thereof | 沈阳海诺威医药科技有限公司 | 2020-08-21 | — | — | CN | claimed |
| US-20120028955-A1 | BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME | VANDERBILT UNIVERSITY | 2012-02-02 | — | — | US | claimed |
| US-20120028956-A1 | BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME | VANDERBILT UNIVERSITY | 2012-02-02 | — | — | US | claimed |
| US-20090270362-A1 | BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME | VANDERBILT UNIVERSITY | 2009-10-29 | — | — | US | claimed |
| US-20090130849-A1 | CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE | EKC TECHNOLOGY, INC. | 2009-05-21 | — | — | US | claimed |
| WO-2009058274-A1 | CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE | EKC TECHNOLOGY, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| US-20090111965-A1 | NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | claimed |
| US-20260042731-A1 | (2,4-DICHLOROPHENOXY)ACETIC ACID ANALOGS | CORTEVA AGRISCIENCE LLC (US) | 2026-02-12 | — | — | US | disclosed |
| WO-2025224512-A1 | NOVEL COMPOUND AS 17-BETA-HYDROXYSTEROID DEHYDROGENASE 13 (HSD17B13) INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 삼진제약주식회사 | 2025-10-30 | — | — | WO | disclosed |
| US-12275723-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2025-04-15 | — | — | US | disclosed |
| US-20040220238-A1 | Pyrrolidine oxadiazole-and thiadiazole derivatives | MERCK SERONO SA (CH) | 2004-11-04 | — | — | US | disclosed |
| WO-2004058254-A1 | HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS | PHARMACIA CORPORATION (US) | 2004-07-15 | — | — | WO | disclosed |
| WO-1997008150-A1 | SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958816-B1 | N′-({[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl}oxy)benzenecarboximidamide as an antimicrobial compound | AADAC, B3GNT2, OGA | KMT2A 3234/4885MEN1 4772/4885GAA 1484/4885 |
| US-20040220238-A1 | Pyrrolidine oxadiazole-and thiadiazole derivatives | OXTR, PRLHR, PGF | KMT2A 4449/4885MEN1 4838/4885GAA 4875/4885 |
| US-20120028955-A1 | BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME | GRM5, GRIK5, GRM1 | KMT2A 1153/4885MEN1 4490/4885GAA 3385/4885 |
| US-12275723-B2 | Compounds and uses thereof | NLN, ACHE, CLN6 | KMT2A 2479/4885MEN1 1807/4885GAA 67/4885 |
| US-11919871-B1 | 3-(3-chlorophenyl)-5-((2-isopropyl-5- methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | OXA1L, API5, CASP3 | KMT2A 2864/4885MEN1 2592/4885GAA 3929/4885 |
| US-20120028956-A1 | BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME | GRM5, GRIK5, GRM1 | KMT2A 1153/4885MEN1 4490/4885GAA 3385/4885 |
| US-12172972-B1 | 3-(3-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | OXA1L, API5, CASP3 | KMT2A 2903/4885MEN1 2183/4885GAA 3924/4885 |
| US-12162845-B1 | 3-(4-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | OXA1L, API5, CASP3 | KMT2A 2752/4885MEN1 2212/4885GAA 3988/4885 |
| US-20260042731-A1 | (2,4-DICHLOROPHENOXY)ACETIC ACID ANALOGS | DDT, AADAC, HACL2 | KMT2A 2330/4885MEN1 1993/4885GAA 1702/4885 |
| US-11958814-B1 | 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | OXA1L, API5, CASP3 | KMT2A 3045/4885MEN1 2744/4885GAA 3543/4885 |
| US-20090111965-A1 | NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION | GNMT, NIT2, NNMT | KMT2A 1813/4885MEN1 1958/4885GAA 2484/4885 |
| US-20090270362-A1 | BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME | GRM5, GRIK5, GRM1 | KMT2A 1153/4885MEN1 4490/4885GAA 3385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.